P

Inventor

REGULA JOERG THOMAS

DE48 patents
⚠️ This page may combine multiple inventors who share the name “REGULA JOERG THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

33 patents
US11306154B2Apr 19, 2022

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

HOFFMANN LA ROCHE13 citations94
US11267903B2Mar 8, 2022

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

HOFFMANN LA ROCHE17 citations94
US10392445B2Aug 27, 2019

Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

HOFFMANN LA ROCHE31 citations93
US9914776B2Mar 13, 2018

Bispecific T cell activating antigen binding molecules

HOFFMANN LA ROCHE16 citations92
US9708396B2Jul 18, 2017

Bispecific anti-VEGF/anti-ANG-2 antibodies

HOFFMANN LA ROCHE16 citations92
US8361747B2Jan 29, 2013

Antibodies against human angiopoietin 2

HOFFMANN LA ROCHE10 citations92
US11603411B2Mar 14, 2023

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE9 citations85
US10941205B2Mar 9, 2021

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE10 citations85
US11091541B2Aug 17, 2021

Human FcRn-binding modified antibodies and methods of use

HOFFMANN LA ROCHE6 citations84
US10611841B2Apr 7, 2020

Bispecific T cell activating antigen binding molecules

HOFFMANN LA ROCHE4 citations84
US10611840B2Apr 7, 2020

Bispecific T cell activating antigen binding molecules

HOFFMANN LA ROCHE4 citations84
US9340609B2May 17, 2016

Antibodies against human angiopoietin 2

HOFFMANN LA ROCHE3 citations84
US10287352B2May 14, 2019

Bispecific antibodies specific for PD1 and TIM3

HOFFMANN LA ROCHE10 citations82
US7625996B2Dec 1, 2009

Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

HOFFMANN LA ROCHE14 citations82
US11673945B2Jun 13, 2023

Bispecific antigen binding proteins

HOFFMANN LA ROCHE4 citations75
US11117965B2Sep 14, 2021

Bispecific T cell activating antigen binding molecules

HOFFMANN LA ROCHE2 citations73
US10640555B2May 5, 2020

Bispecific antigen binding proteins

HOFFMANN LA ROCHE2 citations73
US11787868B2Oct 17, 2023

Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE1 citations72
US10611825B2Apr 7, 2020

Monovalent antigen binding proteins

HOFFMANN LA ROCHE6 citations72
US10538585B2Jan 21, 2020

Anti-ANG2 antibodies and methods of use

HOFFMANN LA ROCHE2 citations72
US11130810B2Sep 28, 2021

Bispecific antibodies specific for PD1 and TIM3

HOFFMANN LA ROCHE4 citations71
US10730938B2Aug 4, 2020

Bispecific antibodies and methods of use in ophthalmology

HOFFMANN LA ROCHE3 citations71
US10087246B2Oct 2, 2018

Anti-PDGF-B antibodies and methods of use

HOFFMANN LA ROCHE2 citations71
US11958912B2Apr 16, 2024

Method for determining the in vivo interaction mode

HOFFMANN LA ROCHE2 citations70
US12264196B2Apr 1, 2025

Fc-receptor binding modified asymmetric antibodies and methods of use

HOFFMANN LA ROCHE1 citations64
US12441812B2Oct 14, 2025

Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

HOFFMANN LA ROCHE0 citations62
US12358997B1Jul 15, 2025

Bispecific anti-human A-beta/anti-human transferrin receptor antibodies

HOFFMANN LA ROCHE0 citations62
US12030952B2Jul 9, 2024

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

HOFFMANN LA ROCHE1 citations62
US10766967B2Sep 8, 2020

Bispecific T cell activating antigen binding molecules

HOFFMANN LA ROCHE1 citations62
US12391757B2Aug 19, 2025

Bispecific antibodies specific for PD1 and TIM3

HOFFMANN LA ROCHE0 citations61
US9073986B2Jul 7, 2015

Antibodies against human angiopoietin 2

HOFFMANN LA ROCHE0 citations52
US10793621B2Oct 6, 2020

Nucleic acid encoding dual Fc antigen binding proteins

HOFFMANN LA ROCHE0 citations51
US9724425B2Aug 8, 2017

Conjugates of insulin-like growth factor-1 and poly(ethylene glycol)

HOFFMANN LA ROCHE0 citations48

BRINKMANN ULRICH

5 patents

ROCHE GLYCART AG

2 patents

BAEHNER MONIKA

2 patents

IMHOF-JUNG SABINE

2 patents

FISCHER STEPHAN

2 patents

ROCHE PALO ALTO LLC

1 patent

BOSSENMAIER BIRGIT

1 patent